台股 » 個股 » 和康生 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

和康生

(1783)
可現股當沖
  • 股價
    49.90
  • 漲跌
    ▲0.45
  • 漲幅
    +0.91%
  • 成交量
    140
  • 產業
    上市 生技醫療類股
  • 127人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
和康生 (1783)籌碼相關-兆豐-景美 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw03/2204/0404/2005/0405/1807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3001/0802/2006/0106/1406/2812/1412/2801/2002/1002/224547.55052.55557.5Mar '24May '24Jul '24Sep '24Nov '24Jan '2560d90dAll

兆豐-景美 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/02/20149.10149.8549.4502740.00%
2025/02/17149.9500.0049.9512730.37%
2025/02/13349.5200.0049.4532711.10%
2025/02/10151.5000.0051.6012680.37%
2025/02/07550.241050.3650.50-5263-1.90%
2025/02/061049.5000.0050.90102583.87%
2025/02/04250.151549.9748.60-13242-5.37%
2025/01/22550.9000.0050.3052352.13%
2025/01/171249.82149.9549.80112284.81%
2025/01/16950.71351.0051.0062262.65%
2025/01/15249.3000.0049.3022220.90%
2025/01/14552.1000.0052.1052112.36%
2025/01/1000.00154.0051.70-1198-0.50%
2025/01/09052.201152.0052.30-11190-5.76%
2025/01/08451.53452.7851.7001840.00%
2025/01/07252.2000.0052.1021761.13%
2025/01/0300.00149.7550.10-1146-0.68%
2024/12/30248.8500.0048.8521371.45%
2024/12/27348.6700.0048.6531312.27%
2024/12/24247.0000.0047.0021281.56%
2024/12/20346.8700.0046.9031272.35%
2024/12/19146.3000.0046.3011280.78%
2024/12/1100.00249.3048.65-2121-1.65%
2024/12/0200.00144.7044.80-1106-0.94%
2024/11/29143.9000.0044.6011070.93%
2024/10/18142.3000.0041.9011960.51%
2024/10/11142.7000.0042.8512210.45%
2024/10/01142.3500.0042.5512610.38%
2024/09/1300.001244.1944.20-12397-3.02%
2024/09/12145.55145.5545.2503980.00%
2024/09/11145.1500.0045.1514060.25%
2024/09/10146.0000.0045.1514080.24%
2024/09/06345.5300.0045.5034060.74%
2024/09/05345.1800.0045.2534090.73%
2024/09/04144.8000.0045.0014130.24%
2024/09/03346.2500.0046.1034130.73%
2024/09/02246.5500.0046.5524140.48%
2024/08/2700.00146.3546.50-1432-0.23%
2024/08/2200.001245.1045.60-12429-2.80%
2024/07/19248.63146.5046.5013840.26%
2024/07/1600.000.145.2544.75-0.1328-0.03%
2024/07/1500.00144.8045.20-1331-0.30%
2024/07/1100.00145.2545.00-1329-0.30%
2024/07/03151.00350.5350.40-2284-0.70%
2024/07/0100.00149.9550.20-1214-0.47%
2024/04/2300.00342.7042.80-3160-1.86%
2024/04/08245.0000.0045.3021651.21%
2024/04/03145.8500.0046.0011630.61%
2024/04/02346.5000.0046.3031651.81%
2024/03/26145.8500.0045.3511670.60%
2024/03/22244.9500.0045.0021661.20%
2024/03/14244.6500.0045.6521681.18%
2024/03/12145.3000.0045.6011660.60%
2024/03/11244.7000.0044.7021651.21%
2024/03/05046.7500.0046.4501680.00%
〈大江集團法說〉和康生明年營收續拚雙位數成長 淨利率維持25%Anue鉅亨-2023/11/20
和康生三大業務銷售看旺 明、後年將啟動擴產計畫Anue鉅亨-2023/07/25
和康生全年毛利率有望維持67%水準 今年將取得10張認證Anue鉅亨-2023/05/23
和康生 相關文章